Fig. 1 | Hypertension Research

Fig. 1

From: Efficacy and safety of esaxerenone with and without sodium–glucose cotransporter-2 inhibitor use in hypertensive patients with type 2 diabetes mellitus: a pooled analysis of five clinical studies

Fig. 1

Changes in morning home BP in the overall population (a) and in the SGLT2i and non-SGLT2i subgroups (b) (full analysis set). Mean; error bars denote 95% confidence interval. ***P < 0.001 vs baseline. BP blood pressure, DBP diastolic BP, SBP systolic BP, SGLT2i sodium–glucose cotransporter-2 inhibitor

Back to article page